Dabrafenib and Trametinib With Radiosurgery in Melanoma Brain Mets
Clinical trial NCT01721603 · TERMINATED
Trial details
- NCT number
- NCT01721603
- Sponsor
- University of California, San Francisco
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2016-01-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.